Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

PaxMedica, Inc. Common Stock PXMD OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
28/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

PaxMedica, Inc. Common Stock (PXMD) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 25/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $18M (loss), growing at -30.2%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $3M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 3.16 (strong liquidity). Debt-to-assets is 0%. Total assets: $6M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 67/100 (Partial), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

PXMD SharesGrow Score Overview

37/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — PXMD

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
PXMD: +0%/yr revenue is, -30.2%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet PXMD: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 3.16 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
PXMD: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.02
Volume300
Avg Volume (30D)1.98K
Market Cap$138.89K
Beta (1Y)-0.57
Share Statistics
EPS (TTM)-11.00
Shares Outstanding$1.66M
IPO Date2022-08-26
Employees6
CEOHoward J. Weisman
Financial Highlights & Ratios
EBITDA$-16.15M
Net Income$-18.29M
Operating Income$-16.15M
Total Cash$4.71M
Net Debt$-4.71M
Total Assets$5.68M
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS70424C2035

Price Chart

Track all markets on TradingView
PXMD
PaxMedica, Inc. Common Stock ↗  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.02

People Also View

IMMX
IMMX
Immix Biopharma, Inc.
$9.85
+1.65%
 PALI
PALI
Palisade Bio, Inc.
$2.06
+3.52%
 UNCY
UNCY
Unicycive Therapeutics, Inc.
$6.94
+4.83%
 ALLR
ALLR
Allarity Therapeutics, Inc.
$1.19
-0.76%
 KPRX
KPRX
Kiora Pharmaceuticals, Inc.
$2.44
-0.33%
 APGN
APGN
Apexigen, Inc.
$0.39
+8.48%
 REVB
REVB
Revelation Biosciences, Inc.
$1.20
+0.84%
 HILS
HILS
Hillstream BioPharma, Inc.
$0.24
+5.66%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message